R-nuucell among eight startups chosen for the EP PerMed six-month program The European program EP PerMed has selected eight innovative biotech ventures to advance personalized medicine, allocating six months of dedicated support and funding. The eight projects cover a range of cancer-related and genetic tools, rehabilitation, and tissue recovery solutions. Among them is the Portuguese…